News
Origenis Appoints Dr. Peter Seufer-Wasserthal as Chief Business...
www.finanznachrichten.de
Origenis GmbH, a German biotech company specializing in the discovery and development of highly selective small molecule kinase inhibitors for CNS disorders,...
Baseball - Arm, aber gut - Sport in der Region - SZ.de
www.sueddeutsche.de
Noch nie waren die Baseballer der Haar Disciples so erfolgreich, dennoch müssen sie weiterhin finanziell improvisieren
Origenis announces patent grants for lead small molecule LRRK2...
www.bionity.com
Origenis GmbH announced that the US Patent Office has granted the company two important patents, US9,499,535 and US9,637,491, that protect the further...
Dieses Baby kam wie die Feuerwehr
www.tz.de
Michael Almstetter (34) von der Puchheimer Feuerwehr machte sich zusammen mit Kollegin Sylvia Kössl sofort auf den Weg – und dann ging alles ganz schnell. Almstetter: „Es …
Netzwerk-Profile
LinkedIn: Michael Almstetter - Managing Director - Origenis GmbH | LinkedIn
Sehen Sie sich das Profil von Michael Almstetter auf LinkedIn an, dem weltweit größten beruflichen Netzwerk. 3 Jobs sind im Profil von Michael Almstetter ...
LinkedIn: Michael Almstetter | LinkedIn
Sehen Sie sich das berufliche Profil von Michael Almstetter (Deutschland) auf LinkedIn an. LinkedIn ist das weltweit größte professionelle Netzwerk, das Fach- und Führungskräften wie Michael Almstetter …
Michael Almstetter | Semantic Scholarwww.semanticscholar.org › author › Michael-Almst...
www.semanticscholar.org
Semantic Scholar profile for Michael Almstetter, with 4 highly influential citations and 27 scientific research papers.
Interessen
Neuron23™ Closes $ Million Series A and B Financing led by...
markets.businessinsider.com
SOUTH SAN FRANCISCO, Calif., Dec. 16, PRNewswire/ -- Neuron23™ Inc., an early stage biotechnology company focused on developing precision me...
Origenis GmbH Announces Research Collaboration with U.S. ...
www.businesswire.com
— ... synthesizing novel small molecules that can cross the blood brain barrier,” said Michael Almstetter, Chief Executive Officer, Origenis. › Or...
Neuron23™ Closes $ Million Series A PR Newswire
www.prnewswire.com
— ... Kevin Raidy (Cowen Healthcare Investments), Michael Almstetter (Origenis), and Nancy Stagliano serve on the Board of Directors. › neu...
Impressum | Disciples München-Haar e.V.
www.vereinonline.org
VereinOnline Disciples München-Haar e.V.
Management & Beteiligungen
Michael Almstetter in der Creditreform Firmendatenbank
www.firmenwissen.de
Michael Almstetter steht mit folgenden Firmen in Beziehung. Es gibt derzeit 3 Unternehmen in der Firmendatenbank, mit denen Michael Almstetter in Beziehung steht. Bei der Art der Beziehung kann es sich beispielsweise um eine Position als Manager, Geschäftsführer oder …
Business-Profile
patentbuddy: Michael Almstetter
PURETECH VENTURES
Biographie von Michael Almstetter - The Official Board
www.theofficialboard.de
Michael Almstetter ist derzeit Director bei Neuron23. Bei Neuron23 hat Michael Almstetter 11 Kollegen einschließlich Mario Saltarelli (CEO), Beth Seidenberg ...
Firmen-Mitarbeiter
Team | Origenis | Planegg
www.origenis.de
Our Team of inventors and founders and managers, CEO chemist, CSO biochemist, COO biologist, Michael Almstetter, Dr. Michael Thormann, Dr. Andreas Treml
Private Homepages
Origenis.de - Erfahrungen und Bewertungen
www.webwiki.de
Finden Sie Bewertungen und Erfahrungen zu Origenis.de. Klicken Sie hier für mehr Informationen zu Origenis.de.
Impressum/Datenschutz
heizwerk-baeumlstr.de
Die Heizwerk Bäumlstraße eG wird gesetzlich durch den Vorstand (Michael Almstetter und Wolfgang Schuster) vertreten. Vorsitzender des Aufsichtsrats: Dipl.
Ausbildung
Nomen Est Omen - BioNMR Group - Universitat de Barcelonabionmr.ub.edu/tmp/Nomen_est_Omen_2007.pdf
bionmr.ub.edu
Michael Almstetter a and Miquel Pons. *,b,c. aOrigenis GmbH, Am Klopferspitz 19a, Martinsried Germany. bLaboratory of Biomolecular NMR, Institute for ...
Design and Synthesis of Novel Rofecoxib Analogues as ...
journals.scholarsportal.info
Nasser A. M. Yehia · Walfrido Antuch · Barbara Beck · Sibylle Hess · Vesna Schauer-Vukasinovic · Michael Almstetter · Patrick Furer · Eberhardt Herdtweck ... › ...
Herkunft
Almstetter - Ancestry.com
www.ancestry.com.au
Results of — Michael Almstetter. Residence. …………Germany. United States Patent and Trademark Office, U.S. Patents, › sear...
Besitz
US Pyrazolo[4,3-D]pyrimidines as kinase inhibitors
patentscope.wipo.int
This patent search tool allows you not only to search the PCT database of about 2 million International Applications but also the worldwide patent collections....
Projekte
Chemical Descriptors Library: Acknowledgements
cdelib.sourceforge.net
Henrik Kuhn, Michael Almstetter, David Leahy. Also, people that provided kind and valuable support: Walfrido Antuch, Dimitar Hristozov, Damjan Krstajic, ...
Bücher
Molecular Diversity in Drug Design - Google Books
books.google.de
High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it...
Microreaction Technology: Proceedings of the First International...
books.google.de
Microreaction technology is the logically consistent application of microsystem techniques in chemical reaction and process engineering. Miniaturization in...
Microreaction Technology: Proceedings of the First ...
books.google.co.in
Bernhard Gruber, Michael Almstetter, Martin Heilingbrunner Institut für Organische Chemie und Biochemie, Technische Universität München...
Molecular Diversity in Drug Design
books.google.co.in
Diversity in VeryLarge Libraries Lutz Weber and Michael Almstetter Morphochem AG, Am Klopferspitz 19, Martinsried, Germany Key words: Abstract: ...
Dokumente zum Namen
Michael Almstetter - Academia.eduindependent.academia.edu › MichaelAlmstetter
independent.academia.edu
Michael Almstetter studies Business, Transparency Market Research, and … Technology.
(PDF) ChemInform Abstract: Discovery of New MultiComponent Reactions...
www.academia.edu
ChemInform is a weekly Abstracting Service, delivering concise information at a glance that was extracted from about 100 leading journals. To access a...
[PDF] Crystal Structures of Staphylococcus aureus Methionine DORA 4RIwww.dora.lib4ri.ch › psi › object › psi: › datastream › PDF2
www.dora.lib4ri.ch
Alice Douangamath, Glenn E. Dale, Allan D'Arcy,. Michael Almstetter, Robert Eckl, Annabelle. Frutos-Hoener, Bernd Henkel, Katrin Illgen,. Sven. Nerdinger,.
Quantitative Prediction of Molecular Properties. Directly from ...
axnfilmfestival.hu
Nomen Est Omen: Quantitative Prediction of Molecular Properties. Directly from IUPAC Names. Michael Thormann*. ,a. , David Vidal b. , Michael Almstetter. › document
Wissenschaftliche Veröffentlichungen
dblp: Journal of Chemical Information and Modeling, Volume 46
dblp.uni-trier.de
Bibliographic content of Journal of Chemical Information and Modeling, Volume 46
Michael Thormann - dblp
dblp.org
Michael Thormann, Andreas Klamt , Martin Hornig, Michael Almstetter: COSMOsim: Bioisosteric Similarity Based on COSMO-RS sigma Profiles. › Persons
Veröffentlichungen allgemein
Molecular Diversity in Drug Design | SpringerLink
link.springer.com
High-throughput screening and combinatorial chemistry are two of the most potent weapons ever to have been used in the discovery of new drugs. At a stroke, it...
New MCRs: The first 4-component reaction leading to 2,4-disubstituted...
link.springer.com
New organic reactions allow chemical transformations which were previously not possible. Therefore, new reactions are important contributions to the progre
Diversity in Very Large Libraries | SpringerLinklink.springer.com › chapter
link.springer.com
... in Very Large Libraries. Diversity in Very Large Libraries. Authors; Authors and affiliations. Lutz Weber; Michael Almstetter. Lutz Weber. 1. Michael Almstetter. 1.
Gateway to Biotech: Im Faculty Club im IZB trafen ...
www.presseportal.de
Fördergesellschaft IZB mbH - Prof. Bruno Reichart, Dr. Michael Almstetter von Origenis, Dr. Joachim Vogt von AbbVie und Sebastian Grabert von Euronext präsentierten auf der Biotech Presse-Lounge ...
Artikel & Meinungen
Twitter-Nachrichten: Uživatel Big4Bio:Boston na Twitteru: „From @LaVoieGroup: Q&A ...
@big4bioBOS. From. @LaVoieGroup. : Q&A with Michael Almstetter, CEO, Origenis http://bit.ly/2lfe3Cg. Obrázek. 9:00 odp. · ·Hootsuite. › status
Wikipedia: Gauting Indians - Wikipedia
The first men's team, under coach Michael Almstetter, and supported by imports Ben Regan, Tristan McDonald and Ryan Crotin, finished sixth place with a ... › wiki › G...
About the 17th Annual Biotech in Europe Forum
www.sachsforum.com
... Michael Stein, Executive Chairman of the Board, Valo The…utics Ltd. Michael Almstetter, CEO, Origenis GmbH; Michael Bauer, CEO, Cellestia Biotech AG ... › ...
Sonstiges
Gauting Indians Explained
everything.explained.today
What is Gauting Indians? Explaining what we could find out about Gauting Indians.
Crystal structures of Staphylococcusaureus methionine aminopeptidase...
pubmed.ncbi.nlm.nih.gov
High-resolution crystal structures of Staphylococcus aureus methionine aminopeptidase I in complex with various keto heterocycles and aminoketones were...
Disciples sign Austrian Clemens Cichocki - News - German Baseball...
www.mister-baseball.com
The German Baseball-Bundesliga team Haar Disciples announced the signing of left-handed pitcher and outfielder Clemens CICHOCKI. The 23-year-old was recently
Dirk Fries signs with Disciples - News - German Baseball Leagues...
www.mister-baseball.com
National team pitcher Dirk Fries signed a contract with the HAAR DISCIPLES. The 28-year-old right-hander joins the Munich suburb club
Multicomponent Reactions and Their Libraries - a New Approach to...
hrcak.srce.hr
Classical chemical syntheses from n starting materials usually require sequences of at least n-I preparation steps, including separation and purification of...
Origenis GmbH Announces Global License and Collaboration Agreement...
www.benzinga.com
- Companies Initiate Lead Optimization Program Leveraging the Origenis AI Discovery Platform to Identify RNA-targeted Small Molecule Compounds for ...
CA A1 - Method for the combinatorial search for reactions for...
patents.google.com
Origenis GmbH; Original Assignee: Morphochem Ag: Michael Almstetter: Alexander Doemling: Katrin Illgen: Lutz Weber: Origenis Gmbh; Priority date (The ...
EP A2 - Verfahren zur kombinatorischen reaktionsfindung zur...
patents.google.com
... EP B1 (de; Inventor: Michael Almstetter: Alexander Doemling: Katrin Illgen: Lutz Weber; Current Assignee (The listed assignees may be inaccurate.
US B aminocarbonyl substituted piperazine or diaza-cyclic...
patents.google.com
... US A1 (en; Inventor: Robert Eckl: Roswitha Taube: Michael Almstetter: Michael Thormann: Andreas Treml: Christopher Straub: Zhouliang Chen ...
finance.yahoo.com › news › origenis-gmbh-anno...Origenis GmbH Announces Research Collaboration with U.S. ...
finance.yahoo.com
... and synthesizing novel small molecules that can cross the blood brain barrier,” said Michael Almstetter, Chief Executive Officer, Origenis.
Michael Almstetter - Grasbrunn - Online-Handelsregister Auskunft
www.online-handelsregister.de
In Zusammenhang mit
Gauting Indians - Wikiwand
www.wikiwand.com
The first men's team, under coach Michael Almstetter, and supported by imports Ben Regan, Tristan McDonald and Ryan Crotin, finished sixth place with a ... › Gauti...
US A1 - Novel kinase inhibitors - Google Patents
patents.google.com
Application number: US ,510; Other versions: US B2 (en; Inventor: Michael Thormann: Andreas Treml: Michael Almstetter: Nadine Traube ... › patent
Origenis GmbH Announces Research Collaboration with U.S. ...uk.finance.yahoo.com › news › origenis-gmbh-a...
uk.finance.yahoo.com
Contact. Michael Almstetter, CEO Tel: +49 (0) · Reblog · Share · Tweet · Share.
Origenis Appoints Thomas Loeser as Chief Financial Yahoo Finance
finance.yahoo.com
Origenis' CEO Michael Almstetter commented: “We are delighted to expand our executive management team with Thomas. With his proven ...
Michael Almstetter - Grasbrunn - Handelsregisterauszüge
www.firmenzentrale.de
› handelsregisterauszug-...
Origenis GmbH Announces Global License and Collaboration ...
finance.yahoo.com
... of compounds supporting Expansion in their efforts to develop medicines for RNA-mediated diseases,” Michael Almstetter, CEO of Origenis.
sortiert nach Relevanz / Datum